---
title: "Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295099820.md"
description: "Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sarepta Therapeutics (SRPT) with a $38.00 price target. Zhu, a 5-star analyst in the Healthcare sector, contrasts with the current market consensus, which rates SRPT as a Hold with an average price target of $22.93."
datetime: "2026-08-06T11:19:22.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295099820.md)
  - [en](https://longbridge.com/en/news/295099820.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295099820.md)
generator: "portal-rs"
---

# Wells Fargo Remains a Buy on Sarepta Therapeutics (SRPT)

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sarepta Therapeutics today and set a price target of $38.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

According to TipRanks, Zhu is a 5-star analyst with an average return of 16.0% and a 38.19% success rate. Zhu covers the Healthcare sector, focusing on stocks such as Ionis Pharmaceuticals, Sarepta Therapeutics, and BeOne Medicines.

Currently, the analyst consensus on Sarepta Therapeutics is a Hold with an average price target of $22.93.

### Related Stocks

- [SRPT.US](https://longbridge.com/en/quote/SRPT.US.md)
- [SRPU.US](https://longbridge.com/en/quote/SRPU.US.md)
- [WFC.US](https://longbridge.com/en/quote/WFC.US.md)
- [IONS.US](https://longbridge.com/en/quote/IONS.US.md)
- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)
- [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md)
- [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md)
- [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md)
- [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md)
- [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md)
- [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md)

## Related News & Research

- [Roth MKM Sticks to Its Buy Rating for Coya Therapeutics, Inc. (COYA)](https://longbridge.com/en/news/296711581.md)
- [Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/296781912.md)
- [Elicio Therapeutics to hold one-on-one investor meetings at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/296784575.md)
- [Wedbush Keeps Their Buy Rating on IDEAYA Biosciences (IDYA)](https://longbridge.com/en/news/296510282.md)
- [Relay Therapeutics, Inc. $RLAY Shares Bought by Bank of America Corp DE](https://longbridge.com/en/news/296449661.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**